Source: Fox News
Summary
The Centers for Disease Control and Prevention (CDC) has reported 3,437 clinical cases of Candida auris, a potentially deadly and drug-resistant fungus, across 27 states in the US as of July 25, 2026. California accounts for the highest number of cases, with 873. The fungus can cause serious infections, primarily in hospitals and healthcare settings, and can spread through contaminated surfaces, objects, and people who carry the fungus without symptoms. Those most at risk include patients with severe underlying medical conditions, particularly those using medical devices such as breathing tubes and catheters.
Our Reading
The advice sounds familiar. Candida auris, a fungus that can cause serious infections, has been reported in 27 states, with California having the highest number of cases. The CDC defines a clinical case as detection of C. auris in a specimen collected during medical care, and some clinical specimens may come from sites where the presence of C. auris represents colonization rather than a true infection. Dr. Marc Siegel considers C. auris an “emerging problem of great concern” due to its resistance to multiple antifungal drugs and its tendency to spread in hospital settings. Invasive C. auris infections have been associated with mortality rates of 30% to 72%. The CDC classifies the fungus as an “urgent antimicrobial-resistance threat.” As research continues to develop new treatments, sterilization and disinfection measures in hospitals can be helpful.
This is not the first time we’ve heard about the dangers of antibiotic resistance and the need for new treatments. It’s a reminder that the fight against infectious diseases is ongoing and requires continued research and vigilance.
Author: Evan Null
